T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer
Clinical trial NCT02073916 · COMPLETED
Trial details
- NCT number
- NCT02073916
- Sponsor
- Jenny C. Chang, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2018-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.